Bioequivalence and Bioavailability Forum 05:08 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

A lovely general sentence in an FDA warning letter [GxP / QC / QA]

posted by ElMaestro - Denmark, 2018-07-10 18:28  - Posting: # 19027
Views: 348

Hi all,


"Your acceptance of the passing results based on an assumed laboratory error was insufficient to invalidate the original failing result and conclude the investigation."


This little sentence portrays a general issue in the industry at the moment. Failure is not an option.
How many failed dissolution tests have you seen repeated this way? How many failed stabilities? How many failed A/P runs? And so forth.

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,698 posts in 3,983 threads, 1,237 registered users;
online 9 (0 registered, 9 guests [including 7 identified bots]).

When puzzled, it never hurts to read the primary documents –
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed